Download
1 / 4
0 likes | 4 Views
Europe NGS Automation Market by Product (Platform, Consumables), Sequencing Type (Whole Genome, Exome, Targeted), Application (Drug Discovery, Diagnostics), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) - Forecast to 2030
E N D
Biomedical Research and An Innovative Paradigm for Healthcare : Next-generation sequencing (NGS)
Europe NGS Automation Market – 2023-2030 Meticulous Research®—a leading market research company, published a research report titled, ‘Europe NGS Automation Market by Product (Platform, Consumables), Sequencing Type (Whole Genome, Exome, Targeted), Application (Drug Discovery, Diagnostics), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) - Forecast to 2030.’ According to this latest publication from Meticulous Research®, the NGS automation market in Europe is projected to reach $380.4 million by 2030, at a CAGR of 13.4% from 2023 to 2030. The growth of this market is driven by factors such as the increasing R&D activities in the life sciences industry, the growing demand for NGS automation in laboratories, and the increasing prevalence of chronic diseases such as cancer. In addition, the increasing applications of next-generation sequencing and the rising number of collaborations between companies to develop library preparation protocols are expected to provide significant growth opportunities for this market. However, the high cost of automation workstations is expected to hamper the adoption of NGS automation solutions and restrain the growth of this market. In addition, factors such as regulatory & standardization concerns in diagnostic testing and the requirement of high-skilled personnel for operating automation software are the major challenges to the growth of this market. Download @ https://www.meticulousresearch.com/download-sample- report/cp_id=5644 Sample Report Here Key Players The key players operating in the NGS automation market in Europe are Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group Ltd. (Switzerland), PRIMADAG SAS (France), BRAND GMBH + CO KG (Germany), Hudson Robotics (U.S.), SPT Labtech (U.K.), Thermo Fisher Scientific Inc. (U.S.), and F. Hoffmann-La Roche AG (Switzerland). Europe NGS Automation Market: Future Outlook The Europe NGS automation market is segmented by product, application, sequencing type, and end user. The study also evaluates industry competitors and analyzes the market at the country level. In 2023, based on product, the workstation/robotic platform segment is estimated to account for the largest share of the NGS automation market. The large share of this segment is attributed to factors such as the increasing demand for NGS automation solutions in laboratories and the benefits of NGS automation during library preparation compared to manual processes. Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com
Europe NGS Automation Market – 2023-2030 In 2023, based on application, the clinical diagnostic segment is slated to register the highest growth rate during the forecast period. The high growth of this segment is attributed to the increasing adoption of NGS by diagnostic laboratories to improve their capabilities in diagnosing rare genetic abnormalities, performing genetic profiling for precision oncology, and detecting pathogens in infectious diseases. https://www.meticulousresearch.com/speak-to- Speak analyst/cp_id=5644 To Our Analyst : In 2023, based on sequencing type, the whole genome sequencing segment is expected to account for the largest share of this market. The large market share of this segment is attributed to the high demand for NGS automation solutions for WGS to reduce per sample costs. In 2023, based on end user, the pharmaceutical & biotechnology companies segment is poised to command the largest share of this market. The large share of this segment is attributed to the increasing R&D expenditure by pharmaceutical and biotechnology companies and the rising demand for new drug development and discovery. Additionally, the financial capability of pharmaceutical & biotechnology companies to acquire highly sophisticated NGS automation workstations boosts the growth of this segment. Quick Buy @ https://www.meticulousresearch.com/Checkout/49228067 Key questions answered in the report: •Which are the high-growth market segments in terms of product, application, sequencing type, end user, and country? •What was the historical market size for the NGS automation solutions across Europe? •What are the market forecasts and estimates for the period 2023–2030? •What are the major drivers, restraints, opportunities, and challenges in the Europe NGS automation market? •Who are the major players in the Europe NGS automation market? •How is the competitive landscape, and who are the market leaders in the Europe NGS automation market? •What are the recent developments in the Europe NGS automation market? •What are the different strategies adopted by the major players in the Europe NGS automation market? •What are the geographical trends and high-growth countries in Europe? Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com
Europe NGS Automation Market – 2023-2030 Contact Us : Mr. Khushal Bombe Meticulous Market Research Inc. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- sales@meticulousresearch.com Visit Our Website: https://www.meticulousresearch.com/ Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com
